Mizuno Masashi, Ito Yasuhiko, Suzuki Yasuhiro, Sakata Fumiko, Saka Yosuke, Hiramatsu Takeyuki, Tamai Hirofumi, Mizutani Makoto, Naruse Tomohiko, Ohashi Norimi, Kasuga Hirotake, Shimizu Hideaki, Kurata Hisashi, Kurata Kei, Suzuki Satoshi, Kido Satoko, Tsuruta Yoshikazu, Matsuoka Teppei, Horie Masanobu, Maruyama Shoichi, Matsuo Seiichi
Division of Nephrology, Renal Replacement Therapy, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Division of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Clin Exp Nephrol. 2016 Dec;20(6):960-971. doi: 10.1007/s10157-016-1249-9. Epub 2016 Mar 7.
Early withdrawal within 3 years after starting peritoneal dialysis (PD) and PD-related peritonitis have been major obstacles preventing increases in the population of PD patients. To address these problems, we implemented education programs for medical staff. This study analyzed the recent status and outcomes of PD therapy, focusing on findings such as the incidence and prognosis of peritonitis as of 5 years after our last study.
We investigated background, laboratory data and status of PD therapy, reasons for withdrawal from PD and incidental statements on peritonitis from 2010 to 2012 (R2), and compared findings with those from our last study of 2005-2007 (R1).
Early PD therapy withdrawal in R2 clearly improved to 44.7 %, compared with 50.9 % in R1. Peritonitis incidence improved slightly from once per 42.8 months/patient in R1 to once per 47.3 months/patient in R2. Notably, PD-related peritonitis as a cause of mortality improved markedly in R2, but outcomes of PD-related peritonitis did not change significantly between R1 and R2. In contrast, social problems increased as a reason for withdrawal from PD therapy.
Our efforts at education might have been useful for improving early withdrawal from PD and deaths attributable to PD-related peritonitis. However, since improvements to incidence of PD-related peritonitis were limited by education, further improvement in PD-related peritonitis incidence requires development of new sterilized connecting systems during PD-bag exchanges to decrease PD-related peritonitis opportunities. Construction of medical support systems to address social problems is required to maintain long-term PD therapy.
腹膜透析(PD)开始后3年内的早期退出以及与PD相关的腹膜炎一直是阻碍PD患者群体增加的主要障碍。为解决这些问题,我们为医务人员实施了教育计划。本研究分析了PD治疗的近期状况和结果,重点关注自我们上次研究5年后的腹膜炎发病率和预后等结果。
我们调查了2010年至2012年(R2)的背景、实验室数据和PD治疗状况、退出PD的原因以及关于腹膜炎的附带陈述,并将结果与我们上次2005 - 2007年研究(R1)的结果进行比较。
R2中早期PD治疗退出率明显改善至44.7%,而R1中为50.9%。腹膜炎发病率略有改善,从R1的每42.8个月/患者发生一次,提高到R2的每47.3个月/患者发生一次。值得注意的是,R2中作为死亡原因的与PD相关的腹膜炎有显著改善,但R1和R2之间与PD相关的腹膜炎结果没有显著变化。相比之下,作为退出PD治疗的原因,社会问题有所增加。
我们的教育努力可能有助于改善PD的早期退出以及与PD相关的腹膜炎所致死亡。然而,由于与PD相关的腹膜炎发病率的改善受教育程度有限,进一步提高与PD相关的腹膜炎发病率需要在更换PD袋期间开发新的无菌连接系统,以减少与PD相关的腹膜炎发生机会。需要构建医疗支持系统来解决社会问题,以维持长期的PD治疗。